|
|
|
Volumn 65, Issue 7-8, 2008, Pages 321-328
|
|
Influence of antiplatelet drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part II. Influence of treatment on time of remission and patients survival;Wpłw leków przeciwpłytkowych (LPP) na efektywność skojarzonego leczenia chorych na drobnokomórkowego raka płuca. Cześć II. Wpływ leczenia na czasokres remisji i przezycia chorych.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ANTITHROMBOCYTIC AGENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
HUMAN;
LUNG SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
SURVIVAL RATE;
THROMBOCYTE AGGREGATION;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PLATELET AGGREGATION;
PLATELET AGGREGATION INHIBITORS;
REMISSION INDUCTION;
SMALL CELL LUNG CARCINOMA;
SURVIVAL RATE;
|
|
EID: 60549088605
PISSN: 00332240
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
